Patents by Inventor E. John Lee

E. John Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-ICOS ANTIBODIES
    Publication number: 20240158502
    Abstract: Antibodies that bind ICOS (Inducible T cell Co-Stimulator). Therapeutic use of anti-ICOS antibodies for modulating the ratio between regulatory T cells and effector T cells, to stimulate the immune system of patients, including use in treating cancers. Methods of producing anti-ICOS antibodies, including species cross-reactive antibodies, using transgenic knock-out mice.
    Type: Application
    Filed: November 1, 2023
    Publication date: May 16, 2024
    Inventors: Richard Charles Alfred SAINSON, Stephen John ARKINSTALL, Jamie Iain CAMPBELL, Mohammed Hanif ALI, E-Chiang LEE, Matthew John MCCOURT, Volker GERMASCHEWSKI, Ian KIRBY, Miha KOSMAC, Nahida PARVEEN, Robert ROWLANDS, Gwenoline BORHIS
  • Tablet formation
    Patent number: 7108864
    Abstract: Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the group consisting of a binder in an amount of from about 2 to about 25% and a superdisintegrant in an amount from about 6 to about 40% where the rapidly precipitating drug, “binder” and superdisintegrant are mixed and compressed into a tablet without heating, solvent or grinding.
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: September 19, 2006
    Assignee: Pharmacia & Upjohn Company
    Inventors: Alice C. Martino, Ashley H. Bates, Walter Morozowich, E. John Lee
  • Delavirdine high strength tablet formulation
    Patent number: 6177101
    Abstract: Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the group consisting of a binder in an amount of from about 2 to about 25% and a superdisintegrant in an amount from about 6 to about 40% where the rapidly precipitating drug, “binder” and superdisintegrant are mixed and compressed into a tablet without heating, solvent or grinding.
    Type: Grant
    Filed: June 7, 1999
    Date of Patent: January 23, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Alice C. Martino, Ashley H. Bates, Walter Morozowich, E. John Lee